Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
AIDS ; 6(7): 629-33, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1503682

RESUMEN

OBJECTIVE: To reduce the number of HIV-1 Western blot (WB)-indeterminates requiring follow-up and the time taken to provide a clear positive or negative result. DESIGN: In the first of two stages, a testing and follow-up strategy was developed to resolve anti-HIV-1 status of WB-indeterminates. In the second stage, implementation of this strategy was assessed. METHODS: After dividing indeterminates into four groups according to WB profile, samples were tested for anti-HIV-1, anti-HIV-2, anti-HTLV-I antibodies, and HIV-1 antigen using the most sensitive assays available. When testing failed to clarify anti-HIV-1 status, follow-up samples were taken to monitor changes in antibody status. RESULTS: Samples in two out of the four indeterminate groups were negative for anti-HIV-1. The other two groups required additional testing and/or follow-up to distinguish reactivity caused by anti-HIV-1 from cross-reactivity. CONCLUSION: Grouping HIV-1 WB-indeterminates according to profile allows a significant percentage to be reported as anti-HIV-1-negative, while additional testing may allow others to be reported as anti-HIV-1-positive. The remainder require a maximum of 3 months' follow-up to resolve anti-HIV-1 status.


Asunto(s)
Serodiagnóstico del SIDA/métodos , Western Blotting/métodos , Infecciones por VIH/diagnóstico , VIH-1/inmunología , Reacciones Antígeno-Anticuerpo , Australia/epidemiología , Estudios de Seguimiento , Antígenos VIH/inmunología , Infecciones por VIH/epidemiología , Humanos , Monitorización Inmunológica , Estudios Prospectivos , Sensibilidad y Especificidad
2.
Med J Aust ; 153(7): 383-6, 1990 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-2215307

RESUMEN

The presence of antibody to human immunodeficiency virus (HIV) in post-partum women may be inferred by screening the blood of their newborn babies, since maternal IgG antibodies freely cross the placenta. We tested a sample of 10,217 newborns from 10 hospitals covering three areas in Sydney and other metropolitan centres in New South Wales from April to July, 1989. None of the specimens gave a positive test for antibody to HIV. Thus, the prevalence of HIV positive serology in this sample of newborns was found to be zero. It was estimated that the seroprevalence of antibody to HIV among all neonates in the study area was between zero and 0.045% (99% confidence interval). Because newborns are an accessible group for the study of HIV, and can act as surrogates for their mothers, anonymous testing of this sentinel group will remove some of the limitations generalizing the information in the present database of HIV infection in Australia. This study provides baseline data and suggests that there is not a widespread epidemic of HIV infection among heterosexual persons in Australia at the present time and that routine antenatal testing of women for antibody to HIV may not be cost-effective. However, it will be important to repeat this study at regular intervals to detect any increase in HIV seroprevalence.


Asunto(s)
Anticuerpos Anti-VIH/sangre , Infecciones por VIH/epidemiología , VIH-1 , Población Urbana/estadística & datos numéricos , Adulto , Western Blotting , Ensayo de Inmunoadsorción Enzimática , Femenino , Seropositividad para VIH/epidemiología , Humanos , Recién Nacido , Nueva Gales del Sur/epidemiología , Prevalencia
3.
J Infect Dis ; 157(5): 889-96, 1988 May.
Artículo en Inglés | MEDLINE | ID: mdl-2966211

RESUMEN

The present study was undertaken to determine T cell response to primary human immunodeficiency virus (HIV) infection. No significant difference in T cell subsets was found between subjects who later seroconverted and a group of controls. Six subjects had multiple enumerations of T cell subsets done at the time of seroconversion. Initially, total lymphocyte and T cell subset counts were reduced. An inversion of the CD4+:CD8+ ratio due to a rise in the level of CD8+ cells was found later, followed by an appreciable increase in the number of CD8+ cells and further inversion of the CD4+:CD8+ ratio. Finally, the CD8+ cell count returned toward normal but remained higher than the CD4+ cell count; the inverted ratio was maintained. Lymphocyte hyporesponsiveness to mitogens and antigens was found during the seroconversion illness in one subject. In three of five subjects for whom data were available, an increase in the absolute number of CD8+ cells followed a decrease in the serum HIV antigen level.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , Linfocitos T/inmunología , Síndrome de Inmunodeficiencia Adquirida/patología , Antígenos Virales/inmunología , VIH/inmunología , Seropositividad para VIH , Hemocianinas/inmunología , Homosexualidad , Humanos , Recuento de Leucocitos , Activación de Linfocitos , Masculino , Fitohemaglutininas/farmacología , Estudios Prospectivos , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Colaboradores-Inductores/patología , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/patología , Toxoide Tetánico/inmunología
4.
Med J Aust ; 147(6): 275-6, 1987 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-3650679

RESUMEN

The sharing of needles and syringes by intravenous drug abusers has been recognized as a critical factor in the transmission of the human immunodeficiency virus (HIV). In an attempt to reduce the sharing of needles and syringes among intravenous drug abusers, a pilot sterile needle-and-syringe exchange programme was established in an inner city neighbourhood in Sydney. The contents of exchanged syringes were screened for antibody to HIV by the enzyme-linked immunosorbent assay (ELISA); reactive and borderline samples were tested further by the Western Blot method. Of a sample of 300 needles-and-syringes that were exchanged, three (1%) needles-and-syringes were confirmed as containing antibody-seropositive blood by both ELISA and Western Blot methods and thus as being potentially infectious. As only 70% of known positive-control syringes were detected in this study, the proportion of potentially infectious needles-and-syringes that was found may have underestimated the proportion of infectious injection equipment that was returned. These findings highlight the importance of the removal of used needles and syringes from circulation in addition to the supply of sterile equipment. This method of monitoring exchanged needles-and-syringes is suggested as a means to evaluate measures that are designed to reduce the transmission of HIV among intravenous drug abusers. The rapid implementation of sterile needle-and-syringe exchange programmes is imperative to stem the spread of HIV infection.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/transmisión , Anticuerpos Antivirales/análisis , Contaminación de Equipos , VIH/inmunología , Agujas , Trastornos Relacionados con Sustancias/inmunología , Jeringas , Síndrome de Inmunodeficiencia Adquirida/inmunología , Síndrome de Inmunodeficiencia Adquirida/prevención & control , Australia , Humanos , Proyectos Piloto , Esterilización
5.
J Infect Dis ; 155(6): 1113-8, 1987 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3553344

RESUMEN

The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , Anticuerpos Antivirales/análisis , VIH/inmunología , Ensayo de Inmunoadsorción Enzimática , Técnica del Anticuerpo Fluorescente , Anticuerpos Anti-VIH , Homosexualidad , Humanos , Inmunoglobulina G/análisis , Inmunoglobulina M/análisis , Técnicas Inmunológicas , Masculino
6.
Pathology ; 18(4): 438-43, 1986 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3547270

RESUMEN

One thousand sera shown to be reactive by one of two commercial enzyme linked immunosorbent assays (ELISA) for antibodies to the AIDS virus were referred to the NSW State Reference Laboratory for confirmatory assays. Each serum was retested by two commercial ELISA systems (Abbott and ENI), the ENI exclusionary H9 ELISA and an immunofluorescence assay. Three hundred and twenty four sera were reactive by all 3 tests whereas 244 demonstrated concordant non-reactivity. Three hundred and seventy seven sera were reactive by Abbott EIA only and could not be confirmed positive by the ENI ELISA incorporating exclusionary testing, immunofluorescence or Western immunoblot of representative sera. Sera obtained from teaching hospital laboratories were more likely to be positive and less likely to be negative by all 3 tests, and were also less likely to be Abbott EIA reactive only compared with sera obtained from the blood transfusion service. Of the remaining 55 sera, 52 demonstrated a negative immunofluorescent reaction or a pattern of equal fluorescence on AIDS virus infected and control cells. Representative sera were shown to be negative on Western immunoblot analysis. Of the 3 sera which demonstrated immunofluorescence reactivity, one was positive and one was negative by Western immunoblot, and one could not be determined. We conclude that a combination of two ELISAs, one with an exclusionary ELISA test and an immunofluorescence assay is a reliable and simple means of confirming reactive sera for AIDS virus antibodies.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/diagnóstico , Técnica del Anticuerpo Fluorescente , Síndrome de Inmunodeficiencia Adquirida/inmunología , Anticuerpos Antivirales/análisis , Ensayo de Inmunoadsorción Enzimática , Reacciones Falso Positivas , VIH/inmunología , Humanos , Control de Calidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA